ArticleCase reports in oncology

Novel Combination of Metronomic Cyclophosphamide and Darolutamide Induces Sustained Clinical Response in Heavily Treated Prostate Cancer with Prostate-Specific Membrane Antigen-Negative Liver Metastases and Rapid Disease Progression.

Viral M Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.